Altropane (Boston Life Science).
Article Details
- CitationCopy to clipboard
Cattabeni F
Altropane (Boston Life Science).
Curr Opin Investig Drugs. 2002 Nov;3(11):1647-51.
- PubMed ID
- 12476968 [ View in PubMed]
- Abstract
Boston Life Sciences (BLS) is developing Altropane as a potential radio-imaging agent to be used with single photon emission tomography (SPECT), for the early diagnosis of Parkinson's disease (PD) and attention deficit hyperactivity disorder (ADHD) [329661]. Altropane is currently in phase III clinical trials for PD and phase II clinical trials for ADHD.
DrugBank Data that Cites this Article
- Drugs